SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-006540
Filing Date
2022-04-28
Accepted
2022-04-28 16:13:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A kura_defa_14a_2022.htm DEFA14A 18278
2 GRAPHIC img257215804_0.jpg GRAPHIC 1271810
3 GRAPHIC img257215804_1.jpg GRAPHIC 106036
  Complete submission text file 0000950170-22-006540.txt   1915483
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37620 | Film No.: 22866689
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences